Compare Prudential PLC (PUK) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prudential PLC vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Prudential PLC trades at $23.92 (market cap $28.84B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.73 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 2× Prudential PLC's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.33%). Which is the better fit depends on your goals — on Pluang, investors hold Prudential PLC for 119 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.
| PUK | TAK | |
|---|---|---|
Market Cap | $28.84B | $58.74B |
Volume | 3,531,298 | 3,110,994 |
Sector | Financials | Health |
52-Week High | $33.61 | $19.05 |
52-Week Low | $23.54 | $13.23 |
Typical Hold Time | 119 Days | 1 Days |
Enterprise Value | $28.38B | $86.65B |
Dividend Yield | 2.33% | 3.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PUK trades at $23.88, up 1.44% with mixed technical signals showing bearish moving averages but oversold RSI levels. The company demonstrates strong fundamentals with $27.4B revenue, 14.52% net margin, and attractive valuation at 8.4 P/E ratio. Recent strategic moves include exiting emerging markets and focusing on core insurance operations while maintaining consistent dividend payments.
PUK presents a value opportunity with solid profitability and growth trajectory, though near-term technical weakness and emerging market exit execution risks require monitoring. Analyst consensus leans positive with 50% buy ratings, supporting potential upside from current levels if operational improvements materialize as planned.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Prudential PLC
Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.
Read more on PUK →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
